Broderick Brian C Edwards Lifesciences Corp Transaction History

Broderick Brian C

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $57,205 - $72,083	-927 Reduced 8.44%	10,053 $766,000
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $1,385 - $1,867	-20 Reduced 0.18%	10,980 $760,000
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $134,326 - $155,644	1,650 Added 17.65%	11,000 $1.04 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $77,973 - $88,735	1,050 Added 12.65%	9,350 $773,000
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $2.55 Million - $3.27 Million	-37,353 Reduced 81.82%	8,300 $619,000
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $300,650 - $391,608	3,650 Added 8.69%	45,653 $3.77 Million
Q2 2022 Jul 19, 2022	BUY	$86.5 - $128.27 $44,980 - $66,700	520 Added 1.25%	42,003 $3.99 Million
Q1 2022 May 17, 2022	BUY	$101.96 - $128.34 $1.43 Million - $1.81 Million	14,066 Added 51.3%	41,483 $4.88 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $1.56 Million - $1.92 Million	14,698 Added 115.56%	27,417 $3.55 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $1.31 Million - $1.56 Million	12,719 New	12,719 $1.44 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

Stay updated on Broderick Brian C with notifications on news.